Fry Hannah 4

What Happened

• Hannah Fry, Vice President and Controller of Protara Therapeutics, had 1,457 shares withheld by the issuer to satisfy income tax obligations tied to the vesting of restricted stock units. The withholding was recorded at $6.67 per share for a total value of $9,718. This transaction is a tax-withholding disposition (transaction code F), not an open-market sale.

Key Details

• Transaction date: 2026-01-26
• Price per share: $6.67; Shares withheld/disposed: 1,457; Total value: $9,718
• Footnote: F1 — Shares were withheld by the Issuer to satisfy income tax obligations associated with the vesting of an RSU award granted to the reporting person on January 24, 2025.
• Shares owned after the transaction: not reported in the provided filing details
• Filing date: 2026-01-27 (filed one day after the transaction — appears timely)

Context

• This was a routine tax-withholding event tied to RSU vesting (a common administrative disposition). It does not represent an open-market sale or new purchase, and therefore should not be interpreted as a clear signal of insider sentiment about the company. Transaction code F indicates shares were withheld to cover taxes rather than liquidated on the market.